Invest in Sieve Health

Automate & Accelerate Clinical Research Operations through AI based Platform

FIRST GOAL HIT (You can still invest)

$172,276

raised from 29 investors

INVEST

min $250

INVESTMENT TERMS

$4M valuation cap Future Equity

$5K, $10K, $20K, $25K

LEAD INVESTOR

Clinical trials CEO, serial entrepreneur

Successful completion of clinical trials is the gateway for manufacturers of any new drug or device to obtain FDA approval to bring their product to market. The process of identifying and screening potential volunteers to participate in these trials is tedious, time consuming, and costly, as it is primarily a manual process. Use of AI is revolutionizing data analysis and decision making across every industry. Knowing the current processes and challenges related to the recruitment and screening processes for clinical trial, when I heard what Sieve is doing, I had to get involved.

sievehealth.com/about

Houston TX

Technology Healthcare AI

Highlights

The Clinical Trials Market is currently worth ~$47 billion, with 10% CAGR through 2026

30% of Trial Budget is spent on Patient Recruitment yet >80% trials fail to meet recruitment target

Sieve relieves administrative bottleneck in trial recruitment by using AI enabled automation

Upfront visibility & automation reducing > 90% enrollment and > 25% trial timelines

Expand trial access to research naïve community physicians (participation today ~ 5%-7%)

Enhance diversity and decentralization in Clinical Trials

Successful commercial pilots completed with intent to continued paid use by the clients

Ongoing commercial collaboration with multiple research networks & healthcare groups

Our Team

Dr Bhosale has firsthand experienced trial inefficiencies and delays through 12+ years industry experience. We all have loved ones who we have lost or know are suffering because advanced treatments were buried under administrative burden or delayed in development. Sieve aspires to eliminate these inefficiencies and accelerate medical advances.